“how do you think of enrollment form sunrise trail, only 12 sites until now ? not as much as i thought or not ?”
I’ve been thinking about that as well.
Here’s my 2 cents… FWIW
I’ve been tracking the trial sites and posted about it in my post #163655
“I’m not sure how the 12th trial site was identified but I am maintaining a spreadsheet comparing the previous trial sites with the new trial sites. The 12th site added was “Peregrine Pharmaceuticals Investigational Site - Savannah, Georgia, United States, 31404”
So currently there are two sites in Georgia as there were in the PII trial but they are not the same sites. The N.H. site was added as part of the 9 additional sites added in January. And, thank you nh for identifying the site in N.H. If anyone can identify a trial site in their state please post that info and I will replace “Peregrine Pharmaceuticals Investigational Site”. I will periodically post the spreadsheet (As soon as I find out how…!!!)
Spreadsheet Summary:
To date 2 sites are the same
5 are in new States and
5 are in the same States but in different cities”
NOTE:
NO ex-US sites. Why?
In the previous PII trial there were:
24 US sites
2 Georgia sites
15 India sites
7 Russia
5 Ukraine
So…24 US sites and 29 sites in eastern Europe & India.
I would like to bring to everyone’s attention what Steve King & Shan have stated TWICE.
“We also remain on track with our regulatory and ethics approval timeline for rolling out European and Asia-Pacific sites over the next few months.”
In slide 16 of the Roth Presentation:
“Single Phase global registration trial >100 sites (US, EU and Asia Pacific)”
To me that is one giant tell…!!!
1 – E.U. That in NOT Russia, Georgia or the Ukraine.
2 – Asia Pacific is NOT India.
Hmmmm…
What could that signal?
1 - There will be a E.U. partner
2 – There will be a Asia Pacific partner
NOTE: Slide 19 lists many powerhouse E.U. BP’s & we have our Asia Pacific candidate in Takeda
When…? ”Over the next few months”
With 2 BP’s we get the long awaited hockey stick.
Regards
golfho
